Published in Medical Letter on the CDC and FDA, December 19th, 2004
They reported on this new antiviral drug candidate in the Journal of Virology.
An outbreak of the smallpox virus is considered to be one of the greatest threats facing the world today. No antiviral drug has proved effective against human smallpox. One antiviral currently available for treatment of orthopoxviruses offers some defense but must be administered intravenously and has a high risk of adverse side...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.